Atlas Trials

Adjuvant Low-dose Ketamine in Pediatric Sickle Cell Vaso-occlusive Crisis

Clinical trial NCT03296345 · COMPLETED

Trial details

NCT number
NCT03296345
Sponsor
UCSF Benioff Children's Hospital Oakland
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Sickle Cell DiseaseVaso-Occlusive Crisis
Start date
2016-06-01
Primary completion
2018-04-01
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.